Bayesian sample size determination using commensurate priors to leverage preexperimental data

被引:5
作者
Zheng, Haiyan [1 ,2 ]
Jaki, Thomas [1 ,3 ]
Wason, James M. S. [2 ]
机构
[1] Univ Cambridge, MRC Biostat Unit, Cambridge CB2 0SR, England
[2] Newcastle Univ, Populat Hlth Sci Inst, Newcastle Upon Tyne, Tyne & Wear, England
[3] Univ Lancaster, Dept Math & Stat, Lancaster, England
基金
英国医学研究理事会;
关键词
Bayesian experimental designs; historical data; rare-disease trials; robustness; sample size; CLINICAL-TRIALS;
D O I
10.1111/biom.13649
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This paper develops Bayesian sample size formulae for experiments comparing two groups, where relevant preexperimental information from multiple sources can be incorporated in a robust prior to support both the design and analysis. We use commensurate predictive priors for borrowing of information and further place Gamma mixture priors on the precisions to account for preliminary belief about the pairwise (in)commensurability between parameters that underpin the historical and new experiments. Averaged over the probability space of the new experimental data, appropriate sample sizes are found according to criteria that control certain aspects of the posterior distribution, such as the coverage probability or length of a defined density region. Our Bayesian methodology can be applied to circumstances that compare two normal means, proportions, or event times. When nuisance parameters (such as variance) in the new experiment are unknown, a prior distribution can further be specified based on preexperimental data. Exact solutions are available based on most of the criteria considered for Bayesian sample size determination, while a search procedure is described in cases for which there are no closed-form expressions. We illustrate the application of our sample size formulae in the design of clinical trials, where pretrial information is available to be leveraged. Hypothetical data examples, motivated by a rare-disease trial with an elicited expert prior opinion, and a comprehensive performance evaluation of the proposed methodology are presented.
引用
收藏
页码:669 / 683
页数:15
相关论文
共 27 条
  • [1] Adcock CJ, 1997, J ROY STAT SOC D-STA, V46, P261
  • [2] Agresti A, 2002, WILEY SERIES PROBABI, DOI [10.1002/0471249688.ch7, DOI 10.1002/0471249688]
  • [3] Ahsanullah M., 2014, Normal and Student's t Distributions and Their Applications, DOI DOI 10.2991/978-94-6239-061-4
  • [4] [Anonymous], 1999, STAT MED, V18, P1905
  • [5] [Anonymous], 2017, ELICITATION SCI ART
  • [6] [Anonymous], 2004, Statistics in practice
  • [7] Mixtures of prior distributions for predictive Bayesian sample size calculations in clinical trials
    Brutti, Pierpaolo
    de Santis, Fulvio
    Gubbiotti, Stefania
    [J]. STATISTICS IN MEDICINE, 2009, 28 (17) : 2185 - 2201
  • [8] Closed form expressions for Bayesian sample size
    Clarke, B.
    Yuan, Ao
    [J]. ANNALS OF STATISTICS, 2006, 34 (03) : 1293 - 1330
  • [9] Using historical data for Bayesian sample size determination
    De Santis, Fulvio
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 2007, 170 : 95 - 113
  • [10] Desu M.M., 1990, STAT MODELING DECISI